Claudia K Fox MD MPH, Dipl ABOM
Pediatric Nutrition, Obesity and Eating Disorders
Associate Professor of Pediatrics, Co-Director of Center for Pediatric Obesity Medicine Pediatrics, University of Minnesota Medical School
Join to View Full Profile
717 Delaware St SEMinneapolis, MN 55414
Phone+1 612-626-6616
Fax+1 612-365-0270
Dr. Fox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Pediatrics, 1995 - 1999- University of Minnesota Medical SchoolClass of 1995
Certifications & Licensure
MN State Medical License 1998 - 2025
American Board of Pediatrics Pediatrics
American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Pediatric Obesity Weight Evaluation Registry (POWER) Study
- SMART Use of Medication for the Treatment of Adolescent Severe Obesity Start of enrollment: 2019 Nov 21
- Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity Start of enrollment: 2021 Aug 04
- Join now to see all
Publications & Presentations
PubMed
- Novel model of childhood appetitive traits in children with obesity.Sunaina Nigam, Mengqi Zhu, Ashley H Shoemaker, Amy C Gross, Claudia K Fox
International Journal of Obesity. 2025-03-27 - 2 citationsLiraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.Claudia K Fox, Margarita Barrientos-Pérez, Eric M Bomberg, John Dcruz, Inge Gies
The New England Journal of Medicine. 2025-02-06 - Should GLP-1 agonists be considered an alternative or adjunct to pediatric metabolic and bariatric surgery? more questions than answers.Marc P Michalsky, Claudia K Fox, Janey S A Pratt
Surgery for Obesity and Related Diseases. 2025-02-01
Press Mentions
Know the Ins and Outs of Prescribing Obesity Medications in Pediatric PatientsOctober 30th, 2024- New Findings on Liraglutide for Younger ChildrenSeptember 18th, 2024
- Liraglutide Efficacious, Safe for Children Aged 6 to <12 YearsSeptember 13th, 2024
- Join now to see all
Grant Support
- Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe ObesityUNIVERSITY OF MINNESOTA2023–2026
- Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe ObesityUNIVERSITY OF MINNESOTA2023–2026
- Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe ObesityUNIVERSITY OF MINNESOTA2023–2026
- SMART Use of Medication for the Treatment ofAdolescent Severe ObesityUNIVERSITY OF MINNESOTA2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
